Guest guest Posted August 10, 2004 Report Share Posted August 10, 2004 > > IAC EXPRESS > Immunization news from the Immunization Action Coalition > =============================================================== > Issue Number 474 August 9, 2004 > > CONTENTS OF THIS ISSUE > > 1. Official CDC Health Advisory reports confirmed case of > measles on an airline flight from Hong Kong to New York > 2. VIS update: CDC issues revised VIS for hepatitis A vaccine > 3. CDC reports on transmission of hepatitis B virus in Georgia > correctional facilities > 4. CDC reports on hepatitis B vaccination of inmates in Texas > correctional facilities > 5. If you vaccinate adults, you can't afford to be without the > " Adults Only Vaccination " kit > 6. IAC makes minor changes to its English and Spanish > patient-education piece " All kids need hepatitis B shots! " > 7. NPI honors recipients of its Excellence in Immunization > awards > 8. NIP web section presents detailed information on needle-free > injection technology > 9. NIP's free web-based training course on smallpox vaccine > storage and handling is approved for CME credit > 10. WHO announces resumption of polio immunization campaigns > in Kano, Nigeria > 11. SIGN's annual meeting scheduled for October 20-22 in > Cape Town, South Africa > --------------------------------------------------------------- > > ABBREVIATIONS: AAFP, American Academy of Family Physicians; AAP, > American Academy of Pediatrics; ACIP, Advisory Committee on > Immunization Practices; CDC, Centers for Disease Control and > Prevention; FDA, Food and Drug Administration; IAC, Immunization > Action Coalition; MMWR, Morbidity and Mortality Weekly Report; > NIP, National Immunization Program; VIS, Vaccine Information > Statement; VPD, vaccine-preventable disease; WHO, World Health > Organization. > --------------------------------------------------------------- > > (1 of 11) > August 9, 2004 > OFFICIAL CDC HEALTH ADVISORY REPORTS CONFIRMED CASE OF MEASLES > ON AN AIRLINE FLIGHT FROM HONG KONG TO NEW YORK > > On August 1, CDC issued an Official CDC Health Advisory about a > confirmed case of measles identified on an airline flight to New > York. On August 2, CDC issued an Official Health Update > correcting some misinformation contained in the health advisory. > Following is the corrected version of the August 1 health > advisory. > > ******************** > > This is an official CDC HEALTH ADVISORY > > Distributed via Health Alert Network > Sunday, August 01, 2004, 19:51 EDT (7:51PM EDT) > > IMPORTED CASE OF MEASLES IDENTIFIED ON AIRLINE FLIGHT INTO > NEW YORK > > On July 31, 2004, the New York City Department of Health and > Mental Hygiene and CDC were notified of a case of measles in a > 2-year-old child. The case was laboratory confirmed at the NYC > public health laboratory on 7/31/04. The child was returning to > the US from travel to Hong Kong, Thailand, and China. The child > did not have a rash but was in the infectious stage of measles > illness during the flight. The child had not been vaccinated > against measles according to the international certificate of > vaccination that the mother had; two siblings did have > documentation of previously receiving MMR. The index case flew > non-stop from Hong Kong to New York, arriving on July 30, 2004, > at approximately 1:40PM on Cathay Pacific flight 830 at F. > Kennedy International Airport. Passengers from this flight > reside in California, Connecticut, Washington DC, Florida, > Georgia, Massachusetts, land, Missouri, North Carolina, New > Jersey, New Hampshire, New York City, New York State, Ohio, > Pennsylvania, Puerto Rico, Texas, and Virginia. > > The Quarantine Station at JFK International Airport is > overseeing notifying jurisdictions of the names of passengers > from the flight. Inquiries regarding passenger names should be > directed to the Quarantine Station at (718) 553-1685. > > CDC estimates that exposures to measles occur, on average, > 10-12 times per year, on commercial aircraft arriving in the > United States. The risk of infection following this type of > exposure in airline contacts is considered low; CDC has only > rarely identified measles cases that apparently resulted from > such exposures. > > State Public Health Departments and health care providers should > be alert to possible cases of measles in persons who traveled on > the July 30th Cathay Pacific flight number 830 or their > contacts. Health care providers should increase their index of > suspicion for measles in clinically compatible cases and notify > their local health department of a suspect measles case > immediately. It is important to obtain travel histories from the > patient and their family, as well as their close contacts. State > health departments should report suspect measles cases > immediately to CDC. Persons generally can be presumed immune to > measles if they have documentation of 2 doses of measles > vaccine, laboratory evidence of immunity to measles, > documentation of physician-diagnosed measles, or were born > before 1957. Persons who are not immune should be given MMR > vaccine or immune globulin according to ACIP recommendations. > > Measles is an acute disease characterized by fever, cough, > coryza, an erythematous maculopapular rash and a pathognomonic > enanthem (Koplik's spots). Measles has an incubation period of > 7-21 days, and infected people are considered contagious from > 4 days before to 4 days after the appearance of rash. Serologic > (Measles IgM) testing is required to confirm the diagnosis. In > addition to serologic specimens, health departments should > collect throat swabs and urine for viral isolation. > > Further information on measles can be found at > http://www.cdc.gov/ncidod/diseases/submenus/sub_measles.htm > > ******************** > --------------------------------------------------------------- > > (2 of 11) > August 9, 2004 > VIS UPDATE: CDC ISSUES REVISED VIS FOR HEPATITIS A VACCINE > > On August 4, CDC issued a revised VIS for hepatitis A vaccine. > The previous VIS for hepatitis A vaccine was issued on 8/25/98. > If you have VISs with that date, discard them, and download and > print the revised VIS from either the NIP website or the IAC > website. Currently, only English-language versions of the > revised VIS are available. IAC EXPRESS will alert readers as > translations become available. > > PLEASE NOTE: When hepatitis A vaccine is added to the Vaccine > Injury Compensation Program's injury table, presumably later in > 2004, another hepatitis A vaccine VIS will be issued. To avoid > large printing expenses, print off only as many of the 8/4/04 > VISs as you anticipate needing for the next several months. > > To access a ready-to-copy (PDF) version of the 8/4/04 > hepatitis A vaccine VIS from the NIP website, go to: > http://www.cdc.gov/nip/publications/VIS/vis-hep-a.pdf > > To access it from the IAC website, go to: > http://www.immunize.org/vis/v-hepa.pdf > --------------------------------------------------------------- > > (3 of 11) > August 9, 2004 > CDC REPORTS ON TRANSMISSION OF HEPATITIS B VIRUS IN GEORGIA > CORRECTIONAL FACILITIES > > CDC published " Transmission of Hepatitis B Virus in Correctional > Facilities--Georgia, January 1999-June 2002 " in the August 6 > issue of MMWR. Reprinted below is a portion of the article, as > well as the entire press summary. > > *********************** > > [The article's opening paragraph] > Incarcerated persons have a disproportionate burden of > infectious diseases, including hepatitis B virus (HBV) > infection. Among U.S. adult prison inmates, the overall > prevalence of current or previous HBV infection ranges from > 13% to 47%. The prevalence of chronic HBV infection among > inmates is approximately 1.0%-3.7%, two to six times the > prevalence among adults in the general U.S. population. > Incarcerated persons can acquire HBV infection in the community > or in correctional settings. This report summarizes the results > of (1) an analysis of hepatitis B cases among Georgia inmates > reported to the Georgia Department of Human Resources, Division > of Public Health (DPH) during January 1999-June 2002, including > a retrospective investigation of cases reported during > January 2001-June 2002; and (2) a prevalence survey conducted in > prison intake centers during February-March 2003. These efforts > identified cases of acute hepatitis B in multiple Georgia > prisons and documented evidence of ongoing transmission of HBV > in the state correctional system. The findings underscore the > need for hepatitis B vaccination programs in correctional > facilities. . . . > > [The complete press summary] > All inmates who receive a medical evaluation in a correctional > facility should be administered hepatitis B vaccine to prevent > ongoing hepatitis B virus transmission in correctional > facilities and to reduce transmission in the community after > incarceration. > > Between January 2001-June 2002, 57 cases of acute hepatitis B > virus infection (HBV) were identified among inmates at 31 long- > term correctional facilities in Georgia. The majority of cases > (72%) were acquired in prison, indicating ongoing HBV > transmission occurred in correctional facilities. The extent of > HBV transmission among inmates might be underestimated since > most persons with acute HBV infection are asymptomatic and > investigations of single cases are not routinely conducted. A > survey at intake centers also showed most incoming inmates were > susceptible to HBV and accepted hepatitis B vaccination (76% and > 78% respectively). The ongoing transmission demonstrated in > Georgia prisons might be occurring in other states, where > similar conditions are likely to exist. Routine hepatitis B > vaccination of inmates would interrupt HBV transmission among > inmates during incarceration and reduce transmission in the > community after incarceration. > > *********************** > > To access a web-text (HTML) version of the complete article, go > to: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5330a2.htm > > To access a ready-to-copy (PDF) version of this issue of MMWR, > go to: http://www.cdc.gov/mmwr/PDF/wk/mm5330.pdf > > To receive a FREE electronic subscription to MMWR (which > includes new ACIP statements), go to: > http://www.cdc.gov/mmwr/mmwrsubscribe.html > --------------------------------------------------------------- > > (4 of 11) > August 9, 2004 > CDC REPORTS ON HEPATITIS B VACCINATION OF INMATES IN TEXAS > CORRECTIONAL FACILITIES > > CDC published " Hepatitis B Vaccination of Inmates in > Correctional Facilities--Texas, 2000-June 2002 " in the August 6 > issue of MMWR. Reprinted below are a portion of the article, as > well as the entire press summary. > > *********************** > > [The article's opening paragraph] > In December 2002, approximately 2.2 million persons were > incarcerated in the United States; an estimated 8 million were > released to the community that year. In 2001, approximately > 22,000 acute hepatitis B cases and 78,000 new hepatitis B virus > (HBV) infections occurred in the United States; an estimated 29% > of these cases were in persons who had been incarcerated > previously. The majority of HBV infections among incarcerated > persons are acquired in the community; however, infection also > is transmitted within correctional settings. Hepatitis B > vaccination of incarcerated persons is recommended to prevent > transmission in correctional facilities and in previously > incarcerated persons on their return to the community. In May > 2000, the Texas Department of Criminal Justice (TDCJ), which > oversees custody of state jail and prison inmates, implemented a > hepatitis B vaccination program. To determine hepatitis B > vaccination rates of inmates during 2000-2002, TDCJ reviewed > charts of inmates released during a 3-day period for > documentation of vaccination. This report summarizes the results > of that study, which indicated that rates of vaccine acceptance > and vaccine series completion among inmates were high. > Establishing hepatitis B vaccination programs in prisons and > jails can prevent a substantial proportion of HBV infections > among adults in the outside community. . . . > > [The complete press summary] > Vaccinating offenders in jails and prisons is feasible, and > may prevent about 30% of new acute hepatitis B cases in the > United States. > > Hepatitis B vaccination in prison has the potential to prevent a > substantial portion of hepatitis B cases in the United States, > since approximately 30% of reported acute hepatitis B cases are > among individuals who have been incarcerated. Although hepatitis > B vaccination in correctional facilities has been recommended > for over 20 years, only five states have implemented vaccination > programs. The Texas Department of Criminal Justice implemented a > hepatitis B vaccination program in its prisons and jails, and > proved that vaccinating inmates was feasible and was well > accepted by inmates and staff. The large majority of both prison > and jail inmates accepted the first dose of vaccine when > offered. Ninety-six percent of prison inmates incarcerated for > 4 months or more received all three vaccine doses. > > *********************** > > To access a web-text (HTML) version of the complete article, go > to: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5330a3.htm > > To access a ready-to-copy (PDF) version of this issue of MMWR, > go to: http://www.cdc.gov/mmwr/PDF/wk/mm5330.pdf > --------------------------------------------------------------- > > (5 of 11) > August 9, 2004 > IF YOU VACCINATE ADULTS, YOU CAN'T AFFORD TO BE WITHOUT THE > " ADULTS ONLY VACCINATION " KIT > > THE GOOD NEWS: More and more adults are being vaccinated, not > only at doctors' offices but also at non-traditional sites, such > as family planning clinics, college health services, STD > clinics, pharmacies, and prisons. > > THE BEST NEWS: IAC has collected ALL the information you need to > vaccinate adults into one user-friendly kit-- " Adults Only > Vaccination: A Step-by-Step Guide " (the AOV kit). > > WHAT IS THE AOV KIT? The kit pares down immunization delivery to > its essential components and presents each component in > manageable, easy-to-master steps. The steps progress in logical > order, starting with setting up a vaccine service at your site > and ending with billing for the vaccine services you've > delivered. > > WHAT'S IN THE KIT? The heart of the kit is the guide, which > presents 157 pages of comprehensive, authoritative, CDC-reviewed > information on ALL aspects of adult immunization. Organized into > seven logically presented steps, the guide is designed to be > useful and stay current for years: it has more than 45 patient > and provider-education materials that will never go out of date > because each is linked to the latest version on IAC's website. > > Plus, the guide is tabbed for easy reference, spiral bound to > lie flat, and plastic coated for durability. And, it has wide > margins for jotting down practical information such as useful > web and email addresses, ideas for improving certain aspects of > vaccine delivery, etc. This allows you to customize your guide > to suit your clinic or practice's unique needs. > > In addition to the guide, the kit contains the following: > > * Two " how-to " instructional videos-- " Immunization Techniques: > Safe, Effective, Caring " and " How to Protect Your Vaccine > Supply " > > * Standing orders protocols for administering eight vaccines > commonly given to adults; these are indispensable for > increasing your clinic or practice's adult immunization rates > > * Vital information for responding to vaccine-related medical > emergencies, such as anaphylaxis, or to power outages > > * A pack of 25 adult immunization record cards > > WHO SUPPORTS THE KIT? Immunization experts from NIP/CDC reviewed > the kit. In addition, the following government agencies signed > the guide's introductory letter: US Department of Health and > Human Services (Women's Health); several divisions within CDC: > the Division of HIV/AIDS Prevention, Division of Sexually > Transmitted Diseases Prevention, and Division of Viral > Hepatitis. The following professional organizations also signed > the letter: the American College Health Association, American > College of Obstetricians and Gynecologists, American Medical > Association, National Medical Association, and Planned > Parenthood Federation of America. > > WHO NEEDS THE KIT? Designed to help integrate immunization > services into sites new to vaccination, the AOV kit is equally > valuable for settings experienced in vaccine delivery. Why? > Because it puts ALL the information you need to vaccinate adults > right at your fingertips. If you currently find any aspect of > adult vaccination confusing, the kit will clarify the issue or > give you resources for getting clarification. IF YOU VACCINATE > ADULTS, YOU CAN'T AFFORD TO BE WITHOUT THE KIT. > > WHAT'S THE PRICE: The kit costs $75. Special discount pricing is > available for orders of 10 or more (see the link below). > > CAN I GET MORE INFORMATION ABOUT THE KIT? You can get complete > information--including a look at the guide's many worksheets, > checklists, protocols, and educational materials--by visiting > IAC's website at http://www.immunize.org/guide > > HOW CAN I ORDER THE KIT? You can order online or by fax or mail, > using a credit card, purchase order, or check. To order, go to: > http://www.immunize.org/guide/index.htm#order Click on the > appropriate link. > --------------------------------------------------------------- > > (6 of 11) > August 9, 2004 > IAC MAKES MINOR CHANGES TO ITS ENGLISH AND SPANISH PATIENT- > EDUCATION PIECE " ALL KIDS NEED HEPATITIS B SHOTS! " > > IAC recently reviewed some of its older patient-education pieces > and made minor revisions to the English and Spanish versions of > one: " All kids need hepatitis B shots! " > > To access a ready-to-copy (PDF) version of the updated " All kids > need hepatitis B shots! " in English, go to: > http://www.immunize.org/catg.d/4055kidb.pdf > > To access it in Spanish, go to: > http://www.immunize.org/catg.d/4055sp.pdf > --------------------------------------------------------------- > > (7 of 11) > August 9, 2004 > NPI HONORS RECIPIENTS OF ITS EXCELLENCE IN IMMUNIZATION AWARDS > > As part of National Immunization Awareness Month, the National > Partnership for Immunization (NPI) honored recipients of its > Excellence in Immunization awards on July 29 at a ceremony in > Washington, DC. Following is information about program > recipients: > > ADDRESSING DISPARITIES AWARDS went to two recipients: > 1. The Pennsylvania Department of Health, Division of > Immunization/Adult Immunization Enhancement Project in > 2003 vaccinated historically underimmunized minority > populations with more than 32,000 doses of influenza vaccine > and more than 1,300 doses of pneumococcal vaccine. For > information, contact Joeanne Maljevac, RN, BC, BSN, at > (717) 787-5681. > > 2. The Turley Family Health Center, Pinellas County, Florida, > increased the number of doses of pediatric vaccines in a > medically underserved neighborhood from 750 doses in 2001 to > 4,115 doses in 2003. For information, contact Hutter, > MD, at (727) 467-2503. > > CAMPAIGN AWARDS went of two recipients: > 1. The Alabama Quality Assurance Foundation's " IZ Alabama > Covered? " Flu and Pneumonia Prevention Campaign aims > to increase influenza and pneumococcal vaccination rates > among senior adults. Recent data show a 66% increase in the > volume of doses of influenza vaccine administered in Alabama > from 2002 to 2003. For information, contact Betsy S. Frazer, > RN, BS, at (205) 970-1600 x3511. > > 2. Visiting Nurse Service,Inc.'s (VNS) Immunization Programs are > helping raise disease awareness and vaccination use in > Indianapolis. The number of influenza and pneumococcal > vaccines given by VNS increased by 22% from 2002 to 2003. VNS > has also raised meningococcal disease awareness and vaccine > use among high school seniors. For information, contact Judy > Moon at (317) 722-8200. > > THE NONTRADITIONAL PARTNER AWARD went to the Southeast Michigan > Partners Project, which brings together distinct communities, > including insurers, employers, and public health and other > stakeholders to develop projects that promote and implement > adult immunization services. For information, contact Terrisca > Des Jardins, MHSA, at (734) 769-1247. > > THE PROVIDER AWARD went to Norman Regional Hospital, which has > evaluated nearly 33,000 patients since 2000 and administered > more than 5,200 doses of pneumococcal vaccine to eligible > patients. For information, contact Yvette on at > (405) 307-1955. > > For additional information on the award-winning projects, go to: > http://www.partnersforimmunization.org/2004recipients.html > --------------------------------------------------------------- > > (8 of 11) > August 9, 2004 > NIP WEB SECTION PRESENTS DETAILED INFORMATION ON NEEDLE-FREE > INJECTION TECHNOLOGY > > NIP's web section Needle-free Injection Technology offers a > wealth of information on the technology involved in > administering vaccines and drugs through the skin without the > use of conventional needles. The section provides background > information, scientific bibliography, history, and links to news > reports, policy sources, device manufacturers, and related > sites. > > Among the resources available is the " Needle-free Injection > Technology News Service, " which distributes news and related > information by WebBoard forum postings and email broadcasts. To > browse as a guest or to subscribe, go to: > http://vaxdev.forum.cdc.gov > > To access all the offerings on the Needle-free Injection > Technology web section, go to: > http://www.cdc.gov/nip/dev/jetinject.htm > --------------------------------------------------------------- > > (9 of 11) > August 9, 2004 > NIP's FREE WEB-BASED TRAINING COURSE ON SMALLPOX VACCINE STORAGE > AND HANDLING IS APPROVED FOR CME CREDIT > > NIP and CDC recently announced the release of Smallpox Vaccine > Storage and Handling, a free interactive web-based training > course approved for CME credit. > > Presented in four modules, the course covers vaccine > distribution, vaccine storage, vaccine preparation and > administration, and procedures and equipment to safeguard the > vaccine during an emergency. The intended audience includes > state and local health department staff; hospital emergency room > technicians, nurses, laboratory workers, and hospital > physicians; private physicians; and first responders. > > To access additional information and the course itself, go to: > http://www2.cdc.gov/nip/isd/spoxvsh/launch1.html > > Email nipinfo@... with questions and comments. > --------------------------------------------------------------- > > (10 of 11) > August 9, 2004 > WHO ANNOUNCES RESUMPTION OF POLIO IMMUNIZATION CAMPAIGNS IN > KANO, NIGERIA > > On August 3, WHO issued a statement on behalf of the Global > Polio Eradication Initiative welcoming the resumption of polio > immunization campaigns in Kano, Nigeria. The first round of > campaigns began in Kano on July 31. Additional campaigns are > planned from September to November throughout Nigeria. > > The statement reported that Kano's decision to vaccinate > children against polio comes at a critical time in the polio > eradication program. Sub-Saharan Africa is on the verge of the > largest polio epidemic in recent history. Because of the > outbreak that originated in Kano and surrounding states, polio > cases recorded in the region are five times greater than they > were during the same period in 2003 (483 compared with 95). > > To access the complete statement, go to: > http://www.who.int/mediacentre/statements/2004/statement4/en/print.html > --------------------------------------------------------------- > > (11 of 11) > August 9, 2004 > SIGN'S ANNUAL MEETING SCHEDULED FOR OCTOBER 20-22 IN CAPE TOWN, > SOUTH AFRICA > > The Safe Injection Global Network (SIGN) recently announced it > will hold its annual meeting on October 20-22 in Cape Town, > South Africa. The meeting has four objectives: > > 1. Exchange information regarding global progress toward the > safe and appropriate use of injections worldwide > 2. Review progress of the various injection safety demonstration > projects in Africa > 3. Review progress of the three WHO needle-stick prevention > projects > 4. Review progress in infection control activities in Africa > > For additional information, go to: > http://www.who.int/injection_safety/en > > Persons interested in participating in the meeting are > encouraged to email the SIGN secretariat at sign@... > > =================================================================== > We hope you will forward this e-newsletter to others. > > Managing Editor: Dale (dale@...) > Editorial Assistant: Janelle Tangonan (janelle@...) > ISSN: 1526-1786 > > To subscribe or change your IACX email address, as well as to view > past issues, please visit http://www.immunize.org/express > > This publication is supported in part by Grant No. U66/CCU524042 > from the National Immunization Program, CDC, and Grant No. > U50/CCU523259 from the Division of Viral Hepatitis, CDC. Its > contents are solely the responsibility of IAC and do not necessarily > represent the official views of CDC. > Circulation: 17,862 > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 10, 2004 Report Share Posted August 10, 2004 > > IAC EXPRESS > Immunization news from the Immunization Action Coalition > =============================================================== > Issue Number 474 August 9, 2004 > > CONTENTS OF THIS ISSUE > > 1. Official CDC Health Advisory reports confirmed case of > measles on an airline flight from Hong Kong to New York > 2. VIS update: CDC issues revised VIS for hepatitis A vaccine > 3. CDC reports on transmission of hepatitis B virus in Georgia > correctional facilities > 4. CDC reports on hepatitis B vaccination of inmates in Texas > correctional facilities > 5. If you vaccinate adults, you can't afford to be without the > " Adults Only Vaccination " kit > 6. IAC makes minor changes to its English and Spanish > patient-education piece " All kids need hepatitis B shots! " > 7. NPI honors recipients of its Excellence in Immunization > awards > 8. NIP web section presents detailed information on needle-free > injection technology > 9. NIP's free web-based training course on smallpox vaccine > storage and handling is approved for CME credit > 10. WHO announces resumption of polio immunization campaigns > in Kano, Nigeria > 11. SIGN's annual meeting scheduled for October 20-22 in > Cape Town, South Africa > --------------------------------------------------------------- > > ABBREVIATIONS: AAFP, American Academy of Family Physicians; AAP, > American Academy of Pediatrics; ACIP, Advisory Committee on > Immunization Practices; CDC, Centers for Disease Control and > Prevention; FDA, Food and Drug Administration; IAC, Immunization > Action Coalition; MMWR, Morbidity and Mortality Weekly Report; > NIP, National Immunization Program; VIS, Vaccine Information > Statement; VPD, vaccine-preventable disease; WHO, World Health > Organization. > --------------------------------------------------------------- > > (1 of 11) > August 9, 2004 > OFFICIAL CDC HEALTH ADVISORY REPORTS CONFIRMED CASE OF MEASLES > ON AN AIRLINE FLIGHT FROM HONG KONG TO NEW YORK > > On August 1, CDC issued an Official CDC Health Advisory about a > confirmed case of measles identified on an airline flight to New > York. On August 2, CDC issued an Official Health Update > correcting some misinformation contained in the health advisory. > Following is the corrected version of the August 1 health > advisory. > > ******************** > > This is an official CDC HEALTH ADVISORY > > Distributed via Health Alert Network > Sunday, August 01, 2004, 19:51 EDT (7:51PM EDT) > > IMPORTED CASE OF MEASLES IDENTIFIED ON AIRLINE FLIGHT INTO > NEW YORK > > On July 31, 2004, the New York City Department of Health and > Mental Hygiene and CDC were notified of a case of measles in a > 2-year-old child. The case was laboratory confirmed at the NYC > public health laboratory on 7/31/04. The child was returning to > the US from travel to Hong Kong, Thailand, and China. The child > did not have a rash but was in the infectious stage of measles > illness during the flight. The child had not been vaccinated > against measles according to the international certificate of > vaccination that the mother had; two siblings did have > documentation of previously receiving MMR. The index case flew > non-stop from Hong Kong to New York, arriving on July 30, 2004, > at approximately 1:40PM on Cathay Pacific flight 830 at F. > Kennedy International Airport. Passengers from this flight > reside in California, Connecticut, Washington DC, Florida, > Georgia, Massachusetts, land, Missouri, North Carolina, New > Jersey, New Hampshire, New York City, New York State, Ohio, > Pennsylvania, Puerto Rico, Texas, and Virginia. > > The Quarantine Station at JFK International Airport is > overseeing notifying jurisdictions of the names of passengers > from the flight. Inquiries regarding passenger names should be > directed to the Quarantine Station at (718) 553-1685. > > CDC estimates that exposures to measles occur, on average, > 10-12 times per year, on commercial aircraft arriving in the > United States. The risk of infection following this type of > exposure in airline contacts is considered low; CDC has only > rarely identified measles cases that apparently resulted from > such exposures. > > State Public Health Departments and health care providers should > be alert to possible cases of measles in persons who traveled on > the July 30th Cathay Pacific flight number 830 or their > contacts. Health care providers should increase their index of > suspicion for measles in clinically compatible cases and notify > their local health department of a suspect measles case > immediately. It is important to obtain travel histories from the > patient and their family, as well as their close contacts. State > health departments should report suspect measles cases > immediately to CDC. Persons generally can be presumed immune to > measles if they have documentation of 2 doses of measles > vaccine, laboratory evidence of immunity to measles, > documentation of physician-diagnosed measles, or were born > before 1957. Persons who are not immune should be given MMR > vaccine or immune globulin according to ACIP recommendations. > > Measles is an acute disease characterized by fever, cough, > coryza, an erythematous maculopapular rash and a pathognomonic > enanthem (Koplik's spots). Measles has an incubation period of > 7-21 days, and infected people are considered contagious from > 4 days before to 4 days after the appearance of rash. Serologic > (Measles IgM) testing is required to confirm the diagnosis. In > addition to serologic specimens, health departments should > collect throat swabs and urine for viral isolation. > > Further information on measles can be found at > http://www.cdc.gov/ncidod/diseases/submenus/sub_measles.htm > > ******************** > --------------------------------------------------------------- > > (2 of 11) > August 9, 2004 > VIS UPDATE: CDC ISSUES REVISED VIS FOR HEPATITIS A VACCINE > > On August 4, CDC issued a revised VIS for hepatitis A vaccine. > The previous VIS for hepatitis A vaccine was issued on 8/25/98. > If you have VISs with that date, discard them, and download and > print the revised VIS from either the NIP website or the IAC > website. Currently, only English-language versions of the > revised VIS are available. IAC EXPRESS will alert readers as > translations become available. > > PLEASE NOTE: When hepatitis A vaccine is added to the Vaccine > Injury Compensation Program's injury table, presumably later in > 2004, another hepatitis A vaccine VIS will be issued. To avoid > large printing expenses, print off only as many of the 8/4/04 > VISs as you anticipate needing for the next several months. > > To access a ready-to-copy (PDF) version of the 8/4/04 > hepatitis A vaccine VIS from the NIP website, go to: > http://www.cdc.gov/nip/publications/VIS/vis-hep-a.pdf > > To access it from the IAC website, go to: > http://www.immunize.org/vis/v-hepa.pdf > --------------------------------------------------------------- > > (3 of 11) > August 9, 2004 > CDC REPORTS ON TRANSMISSION OF HEPATITIS B VIRUS IN GEORGIA > CORRECTIONAL FACILITIES > > CDC published " Transmission of Hepatitis B Virus in Correctional > Facilities--Georgia, January 1999-June 2002 " in the August 6 > issue of MMWR. Reprinted below is a portion of the article, as > well as the entire press summary. > > *********************** > > [The article's opening paragraph] > Incarcerated persons have a disproportionate burden of > infectious diseases, including hepatitis B virus (HBV) > infection. Among U.S. adult prison inmates, the overall > prevalence of current or previous HBV infection ranges from > 13% to 47%. The prevalence of chronic HBV infection among > inmates is approximately 1.0%-3.7%, two to six times the > prevalence among adults in the general U.S. population. > Incarcerated persons can acquire HBV infection in the community > or in correctional settings. This report summarizes the results > of (1) an analysis of hepatitis B cases among Georgia inmates > reported to the Georgia Department of Human Resources, Division > of Public Health (DPH) during January 1999-June 2002, including > a retrospective investigation of cases reported during > January 2001-June 2002; and (2) a prevalence survey conducted in > prison intake centers during February-March 2003. These efforts > identified cases of acute hepatitis B in multiple Georgia > prisons and documented evidence of ongoing transmission of HBV > in the state correctional system. The findings underscore the > need for hepatitis B vaccination programs in correctional > facilities. . . . > > [The complete press summary] > All inmates who receive a medical evaluation in a correctional > facility should be administered hepatitis B vaccine to prevent > ongoing hepatitis B virus transmission in correctional > facilities and to reduce transmission in the community after > incarceration. > > Between January 2001-June 2002, 57 cases of acute hepatitis B > virus infection (HBV) were identified among inmates at 31 long- > term correctional facilities in Georgia. The majority of cases > (72%) were acquired in prison, indicating ongoing HBV > transmission occurred in correctional facilities. The extent of > HBV transmission among inmates might be underestimated since > most persons with acute HBV infection are asymptomatic and > investigations of single cases are not routinely conducted. A > survey at intake centers also showed most incoming inmates were > susceptible to HBV and accepted hepatitis B vaccination (76% and > 78% respectively). The ongoing transmission demonstrated in > Georgia prisons might be occurring in other states, where > similar conditions are likely to exist. Routine hepatitis B > vaccination of inmates would interrupt HBV transmission among > inmates during incarceration and reduce transmission in the > community after incarceration. > > *********************** > > To access a web-text (HTML) version of the complete article, go > to: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5330a2.htm > > To access a ready-to-copy (PDF) version of this issue of MMWR, > go to: http://www.cdc.gov/mmwr/PDF/wk/mm5330.pdf > > To receive a FREE electronic subscription to MMWR (which > includes new ACIP statements), go to: > http://www.cdc.gov/mmwr/mmwrsubscribe.html > --------------------------------------------------------------- > > (4 of 11) > August 9, 2004 > CDC REPORTS ON HEPATITIS B VACCINATION OF INMATES IN TEXAS > CORRECTIONAL FACILITIES > > CDC published " Hepatitis B Vaccination of Inmates in > Correctional Facilities--Texas, 2000-June 2002 " in the August 6 > issue of MMWR. Reprinted below are a portion of the article, as > well as the entire press summary. > > *********************** > > [The article's opening paragraph] > In December 2002, approximately 2.2 million persons were > incarcerated in the United States; an estimated 8 million were > released to the community that year. In 2001, approximately > 22,000 acute hepatitis B cases and 78,000 new hepatitis B virus > (HBV) infections occurred in the United States; an estimated 29% > of these cases were in persons who had been incarcerated > previously. The majority of HBV infections among incarcerated > persons are acquired in the community; however, infection also > is transmitted within correctional settings. Hepatitis B > vaccination of incarcerated persons is recommended to prevent > transmission in correctional facilities and in previously > incarcerated persons on their return to the community. In May > 2000, the Texas Department of Criminal Justice (TDCJ), which > oversees custody of state jail and prison inmates, implemented a > hepatitis B vaccination program. To determine hepatitis B > vaccination rates of inmates during 2000-2002, TDCJ reviewed > charts of inmates released during a 3-day period for > documentation of vaccination. This report summarizes the results > of that study, which indicated that rates of vaccine acceptance > and vaccine series completion among inmates were high. > Establishing hepatitis B vaccination programs in prisons and > jails can prevent a substantial proportion of HBV infections > among adults in the outside community. . . . > > [The complete press summary] > Vaccinating offenders in jails and prisons is feasible, and > may prevent about 30% of new acute hepatitis B cases in the > United States. > > Hepatitis B vaccination in prison has the potential to prevent a > substantial portion of hepatitis B cases in the United States, > since approximately 30% of reported acute hepatitis B cases are > among individuals who have been incarcerated. Although hepatitis > B vaccination in correctional facilities has been recommended > for over 20 years, only five states have implemented vaccination > programs. The Texas Department of Criminal Justice implemented a > hepatitis B vaccination program in its prisons and jails, and > proved that vaccinating inmates was feasible and was well > accepted by inmates and staff. The large majority of both prison > and jail inmates accepted the first dose of vaccine when > offered. Ninety-six percent of prison inmates incarcerated for > 4 months or more received all three vaccine doses. > > *********************** > > To access a web-text (HTML) version of the complete article, go > to: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5330a3.htm > > To access a ready-to-copy (PDF) version of this issue of MMWR, > go to: http://www.cdc.gov/mmwr/PDF/wk/mm5330.pdf > --------------------------------------------------------------- > > (5 of 11) > August 9, 2004 > IF YOU VACCINATE ADULTS, YOU CAN'T AFFORD TO BE WITHOUT THE > " ADULTS ONLY VACCINATION " KIT > > THE GOOD NEWS: More and more adults are being vaccinated, not > only at doctors' offices but also at non-traditional sites, such > as family planning clinics, college health services, STD > clinics, pharmacies, and prisons. > > THE BEST NEWS: IAC has collected ALL the information you need to > vaccinate adults into one user-friendly kit-- " Adults Only > Vaccination: A Step-by-Step Guide " (the AOV kit). > > WHAT IS THE AOV KIT? The kit pares down immunization delivery to > its essential components and presents each component in > manageable, easy-to-master steps. The steps progress in logical > order, starting with setting up a vaccine service at your site > and ending with billing for the vaccine services you've > delivered. > > WHAT'S IN THE KIT? The heart of the kit is the guide, which > presents 157 pages of comprehensive, authoritative, CDC-reviewed > information on ALL aspects of adult immunization. Organized into > seven logically presented steps, the guide is designed to be > useful and stay current for years: it has more than 45 patient > and provider-education materials that will never go out of date > because each is linked to the latest version on IAC's website. > > Plus, the guide is tabbed for easy reference, spiral bound to > lie flat, and plastic coated for durability. And, it has wide > margins for jotting down practical information such as useful > web and email addresses, ideas for improving certain aspects of > vaccine delivery, etc. This allows you to customize your guide > to suit your clinic or practice's unique needs. > > In addition to the guide, the kit contains the following: > > * Two " how-to " instructional videos-- " Immunization Techniques: > Safe, Effective, Caring " and " How to Protect Your Vaccine > Supply " > > * Standing orders protocols for administering eight vaccines > commonly given to adults; these are indispensable for > increasing your clinic or practice's adult immunization rates > > * Vital information for responding to vaccine-related medical > emergencies, such as anaphylaxis, or to power outages > > * A pack of 25 adult immunization record cards > > WHO SUPPORTS THE KIT? Immunization experts from NIP/CDC reviewed > the kit. In addition, the following government agencies signed > the guide's introductory letter: US Department of Health and > Human Services (Women's Health); several divisions within CDC: > the Division of HIV/AIDS Prevention, Division of Sexually > Transmitted Diseases Prevention, and Division of Viral > Hepatitis. The following professional organizations also signed > the letter: the American College Health Association, American > College of Obstetricians and Gynecologists, American Medical > Association, National Medical Association, and Planned > Parenthood Federation of America. > > WHO NEEDS THE KIT? Designed to help integrate immunization > services into sites new to vaccination, the AOV kit is equally > valuable for settings experienced in vaccine delivery. Why? > Because it puts ALL the information you need to vaccinate adults > right at your fingertips. If you currently find any aspect of > adult vaccination confusing, the kit will clarify the issue or > give you resources for getting clarification. IF YOU VACCINATE > ADULTS, YOU CAN'T AFFORD TO BE WITHOUT THE KIT. > > WHAT'S THE PRICE: The kit costs $75. Special discount pricing is > available for orders of 10 or more (see the link below). > > CAN I GET MORE INFORMATION ABOUT THE KIT? You can get complete > information--including a look at the guide's many worksheets, > checklists, protocols, and educational materials--by visiting > IAC's website at http://www.immunize.org/guide > > HOW CAN I ORDER THE KIT? You can order online or by fax or mail, > using a credit card, purchase order, or check. To order, go to: > http://www.immunize.org/guide/index.htm#order Click on the > appropriate link. > --------------------------------------------------------------- > > (6 of 11) > August 9, 2004 > IAC MAKES MINOR CHANGES TO ITS ENGLISH AND SPANISH PATIENT- > EDUCATION PIECE " ALL KIDS NEED HEPATITIS B SHOTS! " > > IAC recently reviewed some of its older patient-education pieces > and made minor revisions to the English and Spanish versions of > one: " All kids need hepatitis B shots! " > > To access a ready-to-copy (PDF) version of the updated " All kids > need hepatitis B shots! " in English, go to: > http://www.immunize.org/catg.d/4055kidb.pdf > > To access it in Spanish, go to: > http://www.immunize.org/catg.d/4055sp.pdf > --------------------------------------------------------------- > > (7 of 11) > August 9, 2004 > NPI HONORS RECIPIENTS OF ITS EXCELLENCE IN IMMUNIZATION AWARDS > > As part of National Immunization Awareness Month, the National > Partnership for Immunization (NPI) honored recipients of its > Excellence in Immunization awards on July 29 at a ceremony in > Washington, DC. Following is information about program > recipients: > > ADDRESSING DISPARITIES AWARDS went to two recipients: > 1. The Pennsylvania Department of Health, Division of > Immunization/Adult Immunization Enhancement Project in > 2003 vaccinated historically underimmunized minority > populations with more than 32,000 doses of influenza vaccine > and more than 1,300 doses of pneumococcal vaccine. For > information, contact Joeanne Maljevac, RN, BC, BSN, at > (717) 787-5681. > > 2. The Turley Family Health Center, Pinellas County, Florida, > increased the number of doses of pediatric vaccines in a > medically underserved neighborhood from 750 doses in 2001 to > 4,115 doses in 2003. For information, contact Hutter, > MD, at (727) 467-2503. > > CAMPAIGN AWARDS went of two recipients: > 1. The Alabama Quality Assurance Foundation's " IZ Alabama > Covered? " Flu and Pneumonia Prevention Campaign aims > to increase influenza and pneumococcal vaccination rates > among senior adults. Recent data show a 66% increase in the > volume of doses of influenza vaccine administered in Alabama > from 2002 to 2003. For information, contact Betsy S. Frazer, > RN, BS, at (205) 970-1600 x3511. > > 2. Visiting Nurse Service,Inc.'s (VNS) Immunization Programs are > helping raise disease awareness and vaccination use in > Indianapolis. The number of influenza and pneumococcal > vaccines given by VNS increased by 22% from 2002 to 2003. VNS > has also raised meningococcal disease awareness and vaccine > use among high school seniors. For information, contact Judy > Moon at (317) 722-8200. > > THE NONTRADITIONAL PARTNER AWARD went to the Southeast Michigan > Partners Project, which brings together distinct communities, > including insurers, employers, and public health and other > stakeholders to develop projects that promote and implement > adult immunization services. For information, contact Terrisca > Des Jardins, MHSA, at (734) 769-1247. > > THE PROVIDER AWARD went to Norman Regional Hospital, which has > evaluated nearly 33,000 patients since 2000 and administered > more than 5,200 doses of pneumococcal vaccine to eligible > patients. For information, contact Yvette on at > (405) 307-1955. > > For additional information on the award-winning projects, go to: > http://www.partnersforimmunization.org/2004recipients.html > --------------------------------------------------------------- > > (8 of 11) > August 9, 2004 > NIP WEB SECTION PRESENTS DETAILED INFORMATION ON NEEDLE-FREE > INJECTION TECHNOLOGY > > NIP's web section Needle-free Injection Technology offers a > wealth of information on the technology involved in > administering vaccines and drugs through the skin without the > use of conventional needles. The section provides background > information, scientific bibliography, history, and links to news > reports, policy sources, device manufacturers, and related > sites. > > Among the resources available is the " Needle-free Injection > Technology News Service, " which distributes news and related > information by WebBoard forum postings and email broadcasts. To > browse as a guest or to subscribe, go to: > http://vaxdev.forum.cdc.gov > > To access all the offerings on the Needle-free Injection > Technology web section, go to: > http://www.cdc.gov/nip/dev/jetinject.htm > --------------------------------------------------------------- > > (9 of 11) > August 9, 2004 > NIP's FREE WEB-BASED TRAINING COURSE ON SMALLPOX VACCINE STORAGE > AND HANDLING IS APPROVED FOR CME CREDIT > > NIP and CDC recently announced the release of Smallpox Vaccine > Storage and Handling, a free interactive web-based training > course approved for CME credit. > > Presented in four modules, the course covers vaccine > distribution, vaccine storage, vaccine preparation and > administration, and procedures and equipment to safeguard the > vaccine during an emergency. The intended audience includes > state and local health department staff; hospital emergency room > technicians, nurses, laboratory workers, and hospital > physicians; private physicians; and first responders. > > To access additional information and the course itself, go to: > http://www2.cdc.gov/nip/isd/spoxvsh/launch1.html > > Email nipinfo@... with questions and comments. > --------------------------------------------------------------- > > (10 of 11) > August 9, 2004 > WHO ANNOUNCES RESUMPTION OF POLIO IMMUNIZATION CAMPAIGNS IN > KANO, NIGERIA > > On August 3, WHO issued a statement on behalf of the Global > Polio Eradication Initiative welcoming the resumption of polio > immunization campaigns in Kano, Nigeria. The first round of > campaigns began in Kano on July 31. Additional campaigns are > planned from September to November throughout Nigeria. > > The statement reported that Kano's decision to vaccinate > children against polio comes at a critical time in the polio > eradication program. Sub-Saharan Africa is on the verge of the > largest polio epidemic in recent history. Because of the > outbreak that originated in Kano and surrounding states, polio > cases recorded in the region are five times greater than they > were during the same period in 2003 (483 compared with 95). > > To access the complete statement, go to: > http://www.who.int/mediacentre/statements/2004/statement4/en/print.html > --------------------------------------------------------------- > > (11 of 11) > August 9, 2004 > SIGN'S ANNUAL MEETING SCHEDULED FOR OCTOBER 20-22 IN CAPE TOWN, > SOUTH AFRICA > > The Safe Injection Global Network (SIGN) recently announced it > will hold its annual meeting on October 20-22 in Cape Town, > South Africa. The meeting has four objectives: > > 1. Exchange information regarding global progress toward the > safe and appropriate use of injections worldwide > 2. Review progress of the various injection safety demonstration > projects in Africa > 3. Review progress of the three WHO needle-stick prevention > projects > 4. Review progress in infection control activities in Africa > > For additional information, go to: > http://www.who.int/injection_safety/en > > Persons interested in participating in the meeting are > encouraged to email the SIGN secretariat at sign@... > > =================================================================== > We hope you will forward this e-newsletter to others. > > Managing Editor: Dale (dale@...) > Editorial Assistant: Janelle Tangonan (janelle@...) > ISSN: 1526-1786 > > To subscribe or change your IACX email address, as well as to view > past issues, please visit http://www.immunize.org/express > > This publication is supported in part by Grant No. U66/CCU524042 > from the National Immunization Program, CDC, and Grant No. > U50/CCU523259 from the Division of Viral Hepatitis, CDC. Its > contents are solely the responsibility of IAC and do not necessarily > represent the official views of CDC. > Circulation: 17,862 > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 10, 2004 Report Share Posted August 10, 2004 > > IAC EXPRESS > Immunization news from the Immunization Action Coalition > =============================================================== > Issue Number 474 August 9, 2004 > > CONTENTS OF THIS ISSUE > > 1. Official CDC Health Advisory reports confirmed case of > measles on an airline flight from Hong Kong to New York > 2. VIS update: CDC issues revised VIS for hepatitis A vaccine > 3. CDC reports on transmission of hepatitis B virus in Georgia > correctional facilities > 4. CDC reports on hepatitis B vaccination of inmates in Texas > correctional facilities > 5. If you vaccinate adults, you can't afford to be without the > " Adults Only Vaccination " kit > 6. IAC makes minor changes to its English and Spanish > patient-education piece " All kids need hepatitis B shots! " > 7. NPI honors recipients of its Excellence in Immunization > awards > 8. NIP web section presents detailed information on needle-free > injection technology > 9. NIP's free web-based training course on smallpox vaccine > storage and handling is approved for CME credit > 10. WHO announces resumption of polio immunization campaigns > in Kano, Nigeria > 11. SIGN's annual meeting scheduled for October 20-22 in > Cape Town, South Africa > --------------------------------------------------------------- > > ABBREVIATIONS: AAFP, American Academy of Family Physicians; AAP, > American Academy of Pediatrics; ACIP, Advisory Committee on > Immunization Practices; CDC, Centers for Disease Control and > Prevention; FDA, Food and Drug Administration; IAC, Immunization > Action Coalition; MMWR, Morbidity and Mortality Weekly Report; > NIP, National Immunization Program; VIS, Vaccine Information > Statement; VPD, vaccine-preventable disease; WHO, World Health > Organization. > --------------------------------------------------------------- > > (1 of 11) > August 9, 2004 > OFFICIAL CDC HEALTH ADVISORY REPORTS CONFIRMED CASE OF MEASLES > ON AN AIRLINE FLIGHT FROM HONG KONG TO NEW YORK > > On August 1, CDC issued an Official CDC Health Advisory about a > confirmed case of measles identified on an airline flight to New > York. On August 2, CDC issued an Official Health Update > correcting some misinformation contained in the health advisory. > Following is the corrected version of the August 1 health > advisory. > > ******************** > > This is an official CDC HEALTH ADVISORY > > Distributed via Health Alert Network > Sunday, August 01, 2004, 19:51 EDT (7:51PM EDT) > > IMPORTED CASE OF MEASLES IDENTIFIED ON AIRLINE FLIGHT INTO > NEW YORK > > On July 31, 2004, the New York City Department of Health and > Mental Hygiene and CDC were notified of a case of measles in a > 2-year-old child. The case was laboratory confirmed at the NYC > public health laboratory on 7/31/04. The child was returning to > the US from travel to Hong Kong, Thailand, and China. The child > did not have a rash but was in the infectious stage of measles > illness during the flight. The child had not been vaccinated > against measles according to the international certificate of > vaccination that the mother had; two siblings did have > documentation of previously receiving MMR. The index case flew > non-stop from Hong Kong to New York, arriving on July 30, 2004, > at approximately 1:40PM on Cathay Pacific flight 830 at F. > Kennedy International Airport. Passengers from this flight > reside in California, Connecticut, Washington DC, Florida, > Georgia, Massachusetts, land, Missouri, North Carolina, New > Jersey, New Hampshire, New York City, New York State, Ohio, > Pennsylvania, Puerto Rico, Texas, and Virginia. > > The Quarantine Station at JFK International Airport is > overseeing notifying jurisdictions of the names of passengers > from the flight. Inquiries regarding passenger names should be > directed to the Quarantine Station at (718) 553-1685. > > CDC estimates that exposures to measles occur, on average, > 10-12 times per year, on commercial aircraft arriving in the > United States. The risk of infection following this type of > exposure in airline contacts is considered low; CDC has only > rarely identified measles cases that apparently resulted from > such exposures. > > State Public Health Departments and health care providers should > be alert to possible cases of measles in persons who traveled on > the July 30th Cathay Pacific flight number 830 or their > contacts. Health care providers should increase their index of > suspicion for measles in clinically compatible cases and notify > their local health department of a suspect measles case > immediately. It is important to obtain travel histories from the > patient and their family, as well as their close contacts. State > health departments should report suspect measles cases > immediately to CDC. Persons generally can be presumed immune to > measles if they have documentation of 2 doses of measles > vaccine, laboratory evidence of immunity to measles, > documentation of physician-diagnosed measles, or were born > before 1957. Persons who are not immune should be given MMR > vaccine or immune globulin according to ACIP recommendations. > > Measles is an acute disease characterized by fever, cough, > coryza, an erythematous maculopapular rash and a pathognomonic > enanthem (Koplik's spots). Measles has an incubation period of > 7-21 days, and infected people are considered contagious from > 4 days before to 4 days after the appearance of rash. Serologic > (Measles IgM) testing is required to confirm the diagnosis. In > addition to serologic specimens, health departments should > collect throat swabs and urine for viral isolation. > > Further information on measles can be found at > http://www.cdc.gov/ncidod/diseases/submenus/sub_measles.htm > > ******************** > --------------------------------------------------------------- > > (2 of 11) > August 9, 2004 > VIS UPDATE: CDC ISSUES REVISED VIS FOR HEPATITIS A VACCINE > > On August 4, CDC issued a revised VIS for hepatitis A vaccine. > The previous VIS for hepatitis A vaccine was issued on 8/25/98. > If you have VISs with that date, discard them, and download and > print the revised VIS from either the NIP website or the IAC > website. Currently, only English-language versions of the > revised VIS are available. IAC EXPRESS will alert readers as > translations become available. > > PLEASE NOTE: When hepatitis A vaccine is added to the Vaccine > Injury Compensation Program's injury table, presumably later in > 2004, another hepatitis A vaccine VIS will be issued. To avoid > large printing expenses, print off only as many of the 8/4/04 > VISs as you anticipate needing for the next several months. > > To access a ready-to-copy (PDF) version of the 8/4/04 > hepatitis A vaccine VIS from the NIP website, go to: > http://www.cdc.gov/nip/publications/VIS/vis-hep-a.pdf > > To access it from the IAC website, go to: > http://www.immunize.org/vis/v-hepa.pdf > --------------------------------------------------------------- > > (3 of 11) > August 9, 2004 > CDC REPORTS ON TRANSMISSION OF HEPATITIS B VIRUS IN GEORGIA > CORRECTIONAL FACILITIES > > CDC published " Transmission of Hepatitis B Virus in Correctional > Facilities--Georgia, January 1999-June 2002 " in the August 6 > issue of MMWR. Reprinted below is a portion of the article, as > well as the entire press summary. > > *********************** > > [The article's opening paragraph] > Incarcerated persons have a disproportionate burden of > infectious diseases, including hepatitis B virus (HBV) > infection. Among U.S. adult prison inmates, the overall > prevalence of current or previous HBV infection ranges from > 13% to 47%. The prevalence of chronic HBV infection among > inmates is approximately 1.0%-3.7%, two to six times the > prevalence among adults in the general U.S. population. > Incarcerated persons can acquire HBV infection in the community > or in correctional settings. This report summarizes the results > of (1) an analysis of hepatitis B cases among Georgia inmates > reported to the Georgia Department of Human Resources, Division > of Public Health (DPH) during January 1999-June 2002, including > a retrospective investigation of cases reported during > January 2001-June 2002; and (2) a prevalence survey conducted in > prison intake centers during February-March 2003. These efforts > identified cases of acute hepatitis B in multiple Georgia > prisons and documented evidence of ongoing transmission of HBV > in the state correctional system. The findings underscore the > need for hepatitis B vaccination programs in correctional > facilities. . . . > > [The complete press summary] > All inmates who receive a medical evaluation in a correctional > facility should be administered hepatitis B vaccine to prevent > ongoing hepatitis B virus transmission in correctional > facilities and to reduce transmission in the community after > incarceration. > > Between January 2001-June 2002, 57 cases of acute hepatitis B > virus infection (HBV) were identified among inmates at 31 long- > term correctional facilities in Georgia. The majority of cases > (72%) were acquired in prison, indicating ongoing HBV > transmission occurred in correctional facilities. The extent of > HBV transmission among inmates might be underestimated since > most persons with acute HBV infection are asymptomatic and > investigations of single cases are not routinely conducted. A > survey at intake centers also showed most incoming inmates were > susceptible to HBV and accepted hepatitis B vaccination (76% and > 78% respectively). The ongoing transmission demonstrated in > Georgia prisons might be occurring in other states, where > similar conditions are likely to exist. Routine hepatitis B > vaccination of inmates would interrupt HBV transmission among > inmates during incarceration and reduce transmission in the > community after incarceration. > > *********************** > > To access a web-text (HTML) version of the complete article, go > to: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5330a2.htm > > To access a ready-to-copy (PDF) version of this issue of MMWR, > go to: http://www.cdc.gov/mmwr/PDF/wk/mm5330.pdf > > To receive a FREE electronic subscription to MMWR (which > includes new ACIP statements), go to: > http://www.cdc.gov/mmwr/mmwrsubscribe.html > --------------------------------------------------------------- > > (4 of 11) > August 9, 2004 > CDC REPORTS ON HEPATITIS B VACCINATION OF INMATES IN TEXAS > CORRECTIONAL FACILITIES > > CDC published " Hepatitis B Vaccination of Inmates in > Correctional Facilities--Texas, 2000-June 2002 " in the August 6 > issue of MMWR. Reprinted below are a portion of the article, as > well as the entire press summary. > > *********************** > > [The article's opening paragraph] > In December 2002, approximately 2.2 million persons were > incarcerated in the United States; an estimated 8 million were > released to the community that year. In 2001, approximately > 22,000 acute hepatitis B cases and 78,000 new hepatitis B virus > (HBV) infections occurred in the United States; an estimated 29% > of these cases were in persons who had been incarcerated > previously. The majority of HBV infections among incarcerated > persons are acquired in the community; however, infection also > is transmitted within correctional settings. Hepatitis B > vaccination of incarcerated persons is recommended to prevent > transmission in correctional facilities and in previously > incarcerated persons on their return to the community. In May > 2000, the Texas Department of Criminal Justice (TDCJ), which > oversees custody of state jail and prison inmates, implemented a > hepatitis B vaccination program. To determine hepatitis B > vaccination rates of inmates during 2000-2002, TDCJ reviewed > charts of inmates released during a 3-day period for > documentation of vaccination. This report summarizes the results > of that study, which indicated that rates of vaccine acceptance > and vaccine series completion among inmates were high. > Establishing hepatitis B vaccination programs in prisons and > jails can prevent a substantial proportion of HBV infections > among adults in the outside community. . . . > > [The complete press summary] > Vaccinating offenders in jails and prisons is feasible, and > may prevent about 30% of new acute hepatitis B cases in the > United States. > > Hepatitis B vaccination in prison has the potential to prevent a > substantial portion of hepatitis B cases in the United States, > since approximately 30% of reported acute hepatitis B cases are > among individuals who have been incarcerated. Although hepatitis > B vaccination in correctional facilities has been recommended > for over 20 years, only five states have implemented vaccination > programs. The Texas Department of Criminal Justice implemented a > hepatitis B vaccination program in its prisons and jails, and > proved that vaccinating inmates was feasible and was well > accepted by inmates and staff. The large majority of both prison > and jail inmates accepted the first dose of vaccine when > offered. Ninety-six percent of prison inmates incarcerated for > 4 months or more received all three vaccine doses. > > *********************** > > To access a web-text (HTML) version of the complete article, go > to: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5330a3.htm > > To access a ready-to-copy (PDF) version of this issue of MMWR, > go to: http://www.cdc.gov/mmwr/PDF/wk/mm5330.pdf > --------------------------------------------------------------- > > (5 of 11) > August 9, 2004 > IF YOU VACCINATE ADULTS, YOU CAN'T AFFORD TO BE WITHOUT THE > " ADULTS ONLY VACCINATION " KIT > > THE GOOD NEWS: More and more adults are being vaccinated, not > only at doctors' offices but also at non-traditional sites, such > as family planning clinics, college health services, STD > clinics, pharmacies, and prisons. > > THE BEST NEWS: IAC has collected ALL the information you need to > vaccinate adults into one user-friendly kit-- " Adults Only > Vaccination: A Step-by-Step Guide " (the AOV kit). > > WHAT IS THE AOV KIT? The kit pares down immunization delivery to > its essential components and presents each component in > manageable, easy-to-master steps. The steps progress in logical > order, starting with setting up a vaccine service at your site > and ending with billing for the vaccine services you've > delivered. > > WHAT'S IN THE KIT? The heart of the kit is the guide, which > presents 157 pages of comprehensive, authoritative, CDC-reviewed > information on ALL aspects of adult immunization. Organized into > seven logically presented steps, the guide is designed to be > useful and stay current for years: it has more than 45 patient > and provider-education materials that will never go out of date > because each is linked to the latest version on IAC's website. > > Plus, the guide is tabbed for easy reference, spiral bound to > lie flat, and plastic coated for durability. And, it has wide > margins for jotting down practical information such as useful > web and email addresses, ideas for improving certain aspects of > vaccine delivery, etc. This allows you to customize your guide > to suit your clinic or practice's unique needs. > > In addition to the guide, the kit contains the following: > > * Two " how-to " instructional videos-- " Immunization Techniques: > Safe, Effective, Caring " and " How to Protect Your Vaccine > Supply " > > * Standing orders protocols for administering eight vaccines > commonly given to adults; these are indispensable for > increasing your clinic or practice's adult immunization rates > > * Vital information for responding to vaccine-related medical > emergencies, such as anaphylaxis, or to power outages > > * A pack of 25 adult immunization record cards > > WHO SUPPORTS THE KIT? Immunization experts from NIP/CDC reviewed > the kit. In addition, the following government agencies signed > the guide's introductory letter: US Department of Health and > Human Services (Women's Health); several divisions within CDC: > the Division of HIV/AIDS Prevention, Division of Sexually > Transmitted Diseases Prevention, and Division of Viral > Hepatitis. The following professional organizations also signed > the letter: the American College Health Association, American > College of Obstetricians and Gynecologists, American Medical > Association, National Medical Association, and Planned > Parenthood Federation of America. > > WHO NEEDS THE KIT? Designed to help integrate immunization > services into sites new to vaccination, the AOV kit is equally > valuable for settings experienced in vaccine delivery. Why? > Because it puts ALL the information you need to vaccinate adults > right at your fingertips. If you currently find any aspect of > adult vaccination confusing, the kit will clarify the issue or > give you resources for getting clarification. IF YOU VACCINATE > ADULTS, YOU CAN'T AFFORD TO BE WITHOUT THE KIT. > > WHAT'S THE PRICE: The kit costs $75. Special discount pricing is > available for orders of 10 or more (see the link below). > > CAN I GET MORE INFORMATION ABOUT THE KIT? You can get complete > information--including a look at the guide's many worksheets, > checklists, protocols, and educational materials--by visiting > IAC's website at http://www.immunize.org/guide > > HOW CAN I ORDER THE KIT? You can order online or by fax or mail, > using a credit card, purchase order, or check. To order, go to: > http://www.immunize.org/guide/index.htm#order Click on the > appropriate link. > --------------------------------------------------------------- > > (6 of 11) > August 9, 2004 > IAC MAKES MINOR CHANGES TO ITS ENGLISH AND SPANISH PATIENT- > EDUCATION PIECE " ALL KIDS NEED HEPATITIS B SHOTS! " > > IAC recently reviewed some of its older patient-education pieces > and made minor revisions to the English and Spanish versions of > one: " All kids need hepatitis B shots! " > > To access a ready-to-copy (PDF) version of the updated " All kids > need hepatitis B shots! " in English, go to: > http://www.immunize.org/catg.d/4055kidb.pdf > > To access it in Spanish, go to: > http://www.immunize.org/catg.d/4055sp.pdf > --------------------------------------------------------------- > > (7 of 11) > August 9, 2004 > NPI HONORS RECIPIENTS OF ITS EXCELLENCE IN IMMUNIZATION AWARDS > > As part of National Immunization Awareness Month, the National > Partnership for Immunization (NPI) honored recipients of its > Excellence in Immunization awards on July 29 at a ceremony in > Washington, DC. Following is information about program > recipients: > > ADDRESSING DISPARITIES AWARDS went to two recipients: > 1. The Pennsylvania Department of Health, Division of > Immunization/Adult Immunization Enhancement Project in > 2003 vaccinated historically underimmunized minority > populations with more than 32,000 doses of influenza vaccine > and more than 1,300 doses of pneumococcal vaccine. For > information, contact Joeanne Maljevac, RN, BC, BSN, at > (717) 787-5681. > > 2. The Turley Family Health Center, Pinellas County, Florida, > increased the number of doses of pediatric vaccines in a > medically underserved neighborhood from 750 doses in 2001 to > 4,115 doses in 2003. For information, contact Hutter, > MD, at (727) 467-2503. > > CAMPAIGN AWARDS went of two recipients: > 1. The Alabama Quality Assurance Foundation's " IZ Alabama > Covered? " Flu and Pneumonia Prevention Campaign aims > to increase influenza and pneumococcal vaccination rates > among senior adults. Recent data show a 66% increase in the > volume of doses of influenza vaccine administered in Alabama > from 2002 to 2003. For information, contact Betsy S. Frazer, > RN, BS, at (205) 970-1600 x3511. > > 2. Visiting Nurse Service,Inc.'s (VNS) Immunization Programs are > helping raise disease awareness and vaccination use in > Indianapolis. The number of influenza and pneumococcal > vaccines given by VNS increased by 22% from 2002 to 2003. VNS > has also raised meningococcal disease awareness and vaccine > use among high school seniors. For information, contact Judy > Moon at (317) 722-8200. > > THE NONTRADITIONAL PARTNER AWARD went to the Southeast Michigan > Partners Project, which brings together distinct communities, > including insurers, employers, and public health and other > stakeholders to develop projects that promote and implement > adult immunization services. For information, contact Terrisca > Des Jardins, MHSA, at (734) 769-1247. > > THE PROVIDER AWARD went to Norman Regional Hospital, which has > evaluated nearly 33,000 patients since 2000 and administered > more than 5,200 doses of pneumococcal vaccine to eligible > patients. For information, contact Yvette on at > (405) 307-1955. > > For additional information on the award-winning projects, go to: > http://www.partnersforimmunization.org/2004recipients.html > --------------------------------------------------------------- > > (8 of 11) > August 9, 2004 > NIP WEB SECTION PRESENTS DETAILED INFORMATION ON NEEDLE-FREE > INJECTION TECHNOLOGY > > NIP's web section Needle-free Injection Technology offers a > wealth of information on the technology involved in > administering vaccines and drugs through the skin without the > use of conventional needles. The section provides background > information, scientific bibliography, history, and links to news > reports, policy sources, device manufacturers, and related > sites. > > Among the resources available is the " Needle-free Injection > Technology News Service, " which distributes news and related > information by WebBoard forum postings and email broadcasts. To > browse as a guest or to subscribe, go to: > http://vaxdev.forum.cdc.gov > > To access all the offerings on the Needle-free Injection > Technology web section, go to: > http://www.cdc.gov/nip/dev/jetinject.htm > --------------------------------------------------------------- > > (9 of 11) > August 9, 2004 > NIP's FREE WEB-BASED TRAINING COURSE ON SMALLPOX VACCINE STORAGE > AND HANDLING IS APPROVED FOR CME CREDIT > > NIP and CDC recently announced the release of Smallpox Vaccine > Storage and Handling, a free interactive web-based training > course approved for CME credit. > > Presented in four modules, the course covers vaccine > distribution, vaccine storage, vaccine preparation and > administration, and procedures and equipment to safeguard the > vaccine during an emergency. The intended audience includes > state and local health department staff; hospital emergency room > technicians, nurses, laboratory workers, and hospital > physicians; private physicians; and first responders. > > To access additional information and the course itself, go to: > http://www2.cdc.gov/nip/isd/spoxvsh/launch1.html > > Email nipinfo@... with questions and comments. > --------------------------------------------------------------- > > (10 of 11) > August 9, 2004 > WHO ANNOUNCES RESUMPTION OF POLIO IMMUNIZATION CAMPAIGNS IN > KANO, NIGERIA > > On August 3, WHO issued a statement on behalf of the Global > Polio Eradication Initiative welcoming the resumption of polio > immunization campaigns in Kano, Nigeria. The first round of > campaigns began in Kano on July 31. Additional campaigns are > planned from September to November throughout Nigeria. > > The statement reported that Kano's decision to vaccinate > children against polio comes at a critical time in the polio > eradication program. Sub-Saharan Africa is on the verge of the > largest polio epidemic in recent history. Because of the > outbreak that originated in Kano and surrounding states, polio > cases recorded in the region are five times greater than they > were during the same period in 2003 (483 compared with 95). > > To access the complete statement, go to: > http://www.who.int/mediacentre/statements/2004/statement4/en/print.html > --------------------------------------------------------------- > > (11 of 11) > August 9, 2004 > SIGN'S ANNUAL MEETING SCHEDULED FOR OCTOBER 20-22 IN CAPE TOWN, > SOUTH AFRICA > > The Safe Injection Global Network (SIGN) recently announced it > will hold its annual meeting on October 20-22 in Cape Town, > South Africa. The meeting has four objectives: > > 1. Exchange information regarding global progress toward the > safe and appropriate use of injections worldwide > 2. Review progress of the various injection safety demonstration > projects in Africa > 3. Review progress of the three WHO needle-stick prevention > projects > 4. Review progress in infection control activities in Africa > > For additional information, go to: > http://www.who.int/injection_safety/en > > Persons interested in participating in the meeting are > encouraged to email the SIGN secretariat at sign@... > > =================================================================== > We hope you will forward this e-newsletter to others. > > Managing Editor: Dale (dale@...) > Editorial Assistant: Janelle Tangonan (janelle@...) > ISSN: 1526-1786 > > To subscribe or change your IACX email address, as well as to view > past issues, please visit http://www.immunize.org/express > > This publication is supported in part by Grant No. U66/CCU524042 > from the National Immunization Program, CDC, and Grant No. > U50/CCU523259 from the Division of Viral Hepatitis, CDC. Its > contents are solely the responsibility of IAC and do not necessarily > represent the official views of CDC. > Circulation: 17,862 > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 10, 2004 Report Share Posted August 10, 2004 > > IAC EXPRESS > Immunization news from the Immunization Action Coalition > =============================================================== > Issue Number 474 August 9, 2004 > > CONTENTS OF THIS ISSUE > > 1. Official CDC Health Advisory reports confirmed case of > measles on an airline flight from Hong Kong to New York > 2. VIS update: CDC issues revised VIS for hepatitis A vaccine > 3. CDC reports on transmission of hepatitis B virus in Georgia > correctional facilities > 4. CDC reports on hepatitis B vaccination of inmates in Texas > correctional facilities > 5. If you vaccinate adults, you can't afford to be without the > " Adults Only Vaccination " kit > 6. IAC makes minor changes to its English and Spanish > patient-education piece " All kids need hepatitis B shots! " > 7. NPI honors recipients of its Excellence in Immunization > awards > 8. NIP web section presents detailed information on needle-free > injection technology > 9. NIP's free web-based training course on smallpox vaccine > storage and handling is approved for CME credit > 10. WHO announces resumption of polio immunization campaigns > in Kano, Nigeria > 11. SIGN's annual meeting scheduled for October 20-22 in > Cape Town, South Africa > --------------------------------------------------------------- > > ABBREVIATIONS: AAFP, American Academy of Family Physicians; AAP, > American Academy of Pediatrics; ACIP, Advisory Committee on > Immunization Practices; CDC, Centers for Disease Control and > Prevention; FDA, Food and Drug Administration; IAC, Immunization > Action Coalition; MMWR, Morbidity and Mortality Weekly Report; > NIP, National Immunization Program; VIS, Vaccine Information > Statement; VPD, vaccine-preventable disease; WHO, World Health > Organization. > --------------------------------------------------------------- > > (1 of 11) > August 9, 2004 > OFFICIAL CDC HEALTH ADVISORY REPORTS CONFIRMED CASE OF MEASLES > ON AN AIRLINE FLIGHT FROM HONG KONG TO NEW YORK > > On August 1, CDC issued an Official CDC Health Advisory about a > confirmed case of measles identified on an airline flight to New > York. On August 2, CDC issued an Official Health Update > correcting some misinformation contained in the health advisory. > Following is the corrected version of the August 1 health > advisory. > > ******************** > > This is an official CDC HEALTH ADVISORY > > Distributed via Health Alert Network > Sunday, August 01, 2004, 19:51 EDT (7:51PM EDT) > > IMPORTED CASE OF MEASLES IDENTIFIED ON AIRLINE FLIGHT INTO > NEW YORK > > On July 31, 2004, the New York City Department of Health and > Mental Hygiene and CDC were notified of a case of measles in a > 2-year-old child. The case was laboratory confirmed at the NYC > public health laboratory on 7/31/04. The child was returning to > the US from travel to Hong Kong, Thailand, and China. The child > did not have a rash but was in the infectious stage of measles > illness during the flight. The child had not been vaccinated > against measles according to the international certificate of > vaccination that the mother had; two siblings did have > documentation of previously receiving MMR. The index case flew > non-stop from Hong Kong to New York, arriving on July 30, 2004, > at approximately 1:40PM on Cathay Pacific flight 830 at F. > Kennedy International Airport. Passengers from this flight > reside in California, Connecticut, Washington DC, Florida, > Georgia, Massachusetts, land, Missouri, North Carolina, New > Jersey, New Hampshire, New York City, New York State, Ohio, > Pennsylvania, Puerto Rico, Texas, and Virginia. > > The Quarantine Station at JFK International Airport is > overseeing notifying jurisdictions of the names of passengers > from the flight. Inquiries regarding passenger names should be > directed to the Quarantine Station at (718) 553-1685. > > CDC estimates that exposures to measles occur, on average, > 10-12 times per year, on commercial aircraft arriving in the > United States. The risk of infection following this type of > exposure in airline contacts is considered low; CDC has only > rarely identified measles cases that apparently resulted from > such exposures. > > State Public Health Departments and health care providers should > be alert to possible cases of measles in persons who traveled on > the July 30th Cathay Pacific flight number 830 or their > contacts. Health care providers should increase their index of > suspicion for measles in clinically compatible cases and notify > their local health department of a suspect measles case > immediately. It is important to obtain travel histories from the > patient and their family, as well as their close contacts. State > health departments should report suspect measles cases > immediately to CDC. Persons generally can be presumed immune to > measles if they have documentation of 2 doses of measles > vaccine, laboratory evidence of immunity to measles, > documentation of physician-diagnosed measles, or were born > before 1957. Persons who are not immune should be given MMR > vaccine or immune globulin according to ACIP recommendations. > > Measles is an acute disease characterized by fever, cough, > coryza, an erythematous maculopapular rash and a pathognomonic > enanthem (Koplik's spots). Measles has an incubation period of > 7-21 days, and infected people are considered contagious from > 4 days before to 4 days after the appearance of rash. Serologic > (Measles IgM) testing is required to confirm the diagnosis. In > addition to serologic specimens, health departments should > collect throat swabs and urine for viral isolation. > > Further information on measles can be found at > http://www.cdc.gov/ncidod/diseases/submenus/sub_measles.htm > > ******************** > --------------------------------------------------------------- > > (2 of 11) > August 9, 2004 > VIS UPDATE: CDC ISSUES REVISED VIS FOR HEPATITIS A VACCINE > > On August 4, CDC issued a revised VIS for hepatitis A vaccine. > The previous VIS for hepatitis A vaccine was issued on 8/25/98. > If you have VISs with that date, discard them, and download and > print the revised VIS from either the NIP website or the IAC > website. Currently, only English-language versions of the > revised VIS are available. IAC EXPRESS will alert readers as > translations become available. > > PLEASE NOTE: When hepatitis A vaccine is added to the Vaccine > Injury Compensation Program's injury table, presumably later in > 2004, another hepatitis A vaccine VIS will be issued. To avoid > large printing expenses, print off only as many of the 8/4/04 > VISs as you anticipate needing for the next several months. > > To access a ready-to-copy (PDF) version of the 8/4/04 > hepatitis A vaccine VIS from the NIP website, go to: > http://www.cdc.gov/nip/publications/VIS/vis-hep-a.pdf > > To access it from the IAC website, go to: > http://www.immunize.org/vis/v-hepa.pdf > --------------------------------------------------------------- > > (3 of 11) > August 9, 2004 > CDC REPORTS ON TRANSMISSION OF HEPATITIS B VIRUS IN GEORGIA > CORRECTIONAL FACILITIES > > CDC published " Transmission of Hepatitis B Virus in Correctional > Facilities--Georgia, January 1999-June 2002 " in the August 6 > issue of MMWR. Reprinted below is a portion of the article, as > well as the entire press summary. > > *********************** > > [The article's opening paragraph] > Incarcerated persons have a disproportionate burden of > infectious diseases, including hepatitis B virus (HBV) > infection. Among U.S. adult prison inmates, the overall > prevalence of current or previous HBV infection ranges from > 13% to 47%. The prevalence of chronic HBV infection among > inmates is approximately 1.0%-3.7%, two to six times the > prevalence among adults in the general U.S. population. > Incarcerated persons can acquire HBV infection in the community > or in correctional settings. This report summarizes the results > of (1) an analysis of hepatitis B cases among Georgia inmates > reported to the Georgia Department of Human Resources, Division > of Public Health (DPH) during January 1999-June 2002, including > a retrospective investigation of cases reported during > January 2001-June 2002; and (2) a prevalence survey conducted in > prison intake centers during February-March 2003. These efforts > identified cases of acute hepatitis B in multiple Georgia > prisons and documented evidence of ongoing transmission of HBV > in the state correctional system. The findings underscore the > need for hepatitis B vaccination programs in correctional > facilities. . . . > > [The complete press summary] > All inmates who receive a medical evaluation in a correctional > facility should be administered hepatitis B vaccine to prevent > ongoing hepatitis B virus transmission in correctional > facilities and to reduce transmission in the community after > incarceration. > > Between January 2001-June 2002, 57 cases of acute hepatitis B > virus infection (HBV) were identified among inmates at 31 long- > term correctional facilities in Georgia. The majority of cases > (72%) were acquired in prison, indicating ongoing HBV > transmission occurred in correctional facilities. The extent of > HBV transmission among inmates might be underestimated since > most persons with acute HBV infection are asymptomatic and > investigations of single cases are not routinely conducted. A > survey at intake centers also showed most incoming inmates were > susceptible to HBV and accepted hepatitis B vaccination (76% and > 78% respectively). The ongoing transmission demonstrated in > Georgia prisons might be occurring in other states, where > similar conditions are likely to exist. Routine hepatitis B > vaccination of inmates would interrupt HBV transmission among > inmates during incarceration and reduce transmission in the > community after incarceration. > > *********************** > > To access a web-text (HTML) version of the complete article, go > to: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5330a2.htm > > To access a ready-to-copy (PDF) version of this issue of MMWR, > go to: http://www.cdc.gov/mmwr/PDF/wk/mm5330.pdf > > To receive a FREE electronic subscription to MMWR (which > includes new ACIP statements), go to: > http://www.cdc.gov/mmwr/mmwrsubscribe.html > --------------------------------------------------------------- > > (4 of 11) > August 9, 2004 > CDC REPORTS ON HEPATITIS B VACCINATION OF INMATES IN TEXAS > CORRECTIONAL FACILITIES > > CDC published " Hepatitis B Vaccination of Inmates in > Correctional Facilities--Texas, 2000-June 2002 " in the August 6 > issue of MMWR. Reprinted below are a portion of the article, as > well as the entire press summary. > > *********************** > > [The article's opening paragraph] > In December 2002, approximately 2.2 million persons were > incarcerated in the United States; an estimated 8 million were > released to the community that year. In 2001, approximately > 22,000 acute hepatitis B cases and 78,000 new hepatitis B virus > (HBV) infections occurred in the United States; an estimated 29% > of these cases were in persons who had been incarcerated > previously. The majority of HBV infections among incarcerated > persons are acquired in the community; however, infection also > is transmitted within correctional settings. Hepatitis B > vaccination of incarcerated persons is recommended to prevent > transmission in correctional facilities and in previously > incarcerated persons on their return to the community. In May > 2000, the Texas Department of Criminal Justice (TDCJ), which > oversees custody of state jail and prison inmates, implemented a > hepatitis B vaccination program. To determine hepatitis B > vaccination rates of inmates during 2000-2002, TDCJ reviewed > charts of inmates released during a 3-day period for > documentation of vaccination. This report summarizes the results > of that study, which indicated that rates of vaccine acceptance > and vaccine series completion among inmates were high. > Establishing hepatitis B vaccination programs in prisons and > jails can prevent a substantial proportion of HBV infections > among adults in the outside community. . . . > > [The complete press summary] > Vaccinating offenders in jails and prisons is feasible, and > may prevent about 30% of new acute hepatitis B cases in the > United States. > > Hepatitis B vaccination in prison has the potential to prevent a > substantial portion of hepatitis B cases in the United States, > since approximately 30% of reported acute hepatitis B cases are > among individuals who have been incarcerated. Although hepatitis > B vaccination in correctional facilities has been recommended > for over 20 years, only five states have implemented vaccination > programs. The Texas Department of Criminal Justice implemented a > hepatitis B vaccination program in its prisons and jails, and > proved that vaccinating inmates was feasible and was well > accepted by inmates and staff. The large majority of both prison > and jail inmates accepted the first dose of vaccine when > offered. Ninety-six percent of prison inmates incarcerated for > 4 months or more received all three vaccine doses. > > *********************** > > To access a web-text (HTML) version of the complete article, go > to: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5330a3.htm > > To access a ready-to-copy (PDF) version of this issue of MMWR, > go to: http://www.cdc.gov/mmwr/PDF/wk/mm5330.pdf > --------------------------------------------------------------- > > (5 of 11) > August 9, 2004 > IF YOU VACCINATE ADULTS, YOU CAN'T AFFORD TO BE WITHOUT THE > " ADULTS ONLY VACCINATION " KIT > > THE GOOD NEWS: More and more adults are being vaccinated, not > only at doctors' offices but also at non-traditional sites, such > as family planning clinics, college health services, STD > clinics, pharmacies, and prisons. > > THE BEST NEWS: IAC has collected ALL the information you need to > vaccinate adults into one user-friendly kit-- " Adults Only > Vaccination: A Step-by-Step Guide " (the AOV kit). > > WHAT IS THE AOV KIT? The kit pares down immunization delivery to > its essential components and presents each component in > manageable, easy-to-master steps. The steps progress in logical > order, starting with setting up a vaccine service at your site > and ending with billing for the vaccine services you've > delivered. > > WHAT'S IN THE KIT? The heart of the kit is the guide, which > presents 157 pages of comprehensive, authoritative, CDC-reviewed > information on ALL aspects of adult immunization. Organized into > seven logically presented steps, the guide is designed to be > useful and stay current for years: it has more than 45 patient > and provider-education materials that will never go out of date > because each is linked to the latest version on IAC's website. > > Plus, the guide is tabbed for easy reference, spiral bound to > lie flat, and plastic coated for durability. And, it has wide > margins for jotting down practical information such as useful > web and email addresses, ideas for improving certain aspects of > vaccine delivery, etc. This allows you to customize your guide > to suit your clinic or practice's unique needs. > > In addition to the guide, the kit contains the following: > > * Two " how-to " instructional videos-- " Immunization Techniques: > Safe, Effective, Caring " and " How to Protect Your Vaccine > Supply " > > * Standing orders protocols for administering eight vaccines > commonly given to adults; these are indispensable for > increasing your clinic or practice's adult immunization rates > > * Vital information for responding to vaccine-related medical > emergencies, such as anaphylaxis, or to power outages > > * A pack of 25 adult immunization record cards > > WHO SUPPORTS THE KIT? Immunization experts from NIP/CDC reviewed > the kit. In addition, the following government agencies signed > the guide's introductory letter: US Department of Health and > Human Services (Women's Health); several divisions within CDC: > the Division of HIV/AIDS Prevention, Division of Sexually > Transmitted Diseases Prevention, and Division of Viral > Hepatitis. The following professional organizations also signed > the letter: the American College Health Association, American > College of Obstetricians and Gynecologists, American Medical > Association, National Medical Association, and Planned > Parenthood Federation of America. > > WHO NEEDS THE KIT? Designed to help integrate immunization > services into sites new to vaccination, the AOV kit is equally > valuable for settings experienced in vaccine delivery. Why? > Because it puts ALL the information you need to vaccinate adults > right at your fingertips. If you currently find any aspect of > adult vaccination confusing, the kit will clarify the issue or > give you resources for getting clarification. IF YOU VACCINATE > ADULTS, YOU CAN'T AFFORD TO BE WITHOUT THE KIT. > > WHAT'S THE PRICE: The kit costs $75. Special discount pricing is > available for orders of 10 or more (see the link below). > > CAN I GET MORE INFORMATION ABOUT THE KIT? You can get complete > information--including a look at the guide's many worksheets, > checklists, protocols, and educational materials--by visiting > IAC's website at http://www.immunize.org/guide > > HOW CAN I ORDER THE KIT? You can order online or by fax or mail, > using a credit card, purchase order, or check. To order, go to: > http://www.immunize.org/guide/index.htm#order Click on the > appropriate link. > --------------------------------------------------------------- > > (6 of 11) > August 9, 2004 > IAC MAKES MINOR CHANGES TO ITS ENGLISH AND SPANISH PATIENT- > EDUCATION PIECE " ALL KIDS NEED HEPATITIS B SHOTS! " > > IAC recently reviewed some of its older patient-education pieces > and made minor revisions to the English and Spanish versions of > one: " All kids need hepatitis B shots! " > > To access a ready-to-copy (PDF) version of the updated " All kids > need hepatitis B shots! " in English, go to: > http://www.immunize.org/catg.d/4055kidb.pdf > > To access it in Spanish, go to: > http://www.immunize.org/catg.d/4055sp.pdf > --------------------------------------------------------------- > > (7 of 11) > August 9, 2004 > NPI HONORS RECIPIENTS OF ITS EXCELLENCE IN IMMUNIZATION AWARDS > > As part of National Immunization Awareness Month, the National > Partnership for Immunization (NPI) honored recipients of its > Excellence in Immunization awards on July 29 at a ceremony in > Washington, DC. Following is information about program > recipients: > > ADDRESSING DISPARITIES AWARDS went to two recipients: > 1. The Pennsylvania Department of Health, Division of > Immunization/Adult Immunization Enhancement Project in > 2003 vaccinated historically underimmunized minority > populations with more than 32,000 doses of influenza vaccine > and more than 1,300 doses of pneumococcal vaccine. For > information, contact Joeanne Maljevac, RN, BC, BSN, at > (717) 787-5681. > > 2. The Turley Family Health Center, Pinellas County, Florida, > increased the number of doses of pediatric vaccines in a > medically underserved neighborhood from 750 doses in 2001 to > 4,115 doses in 2003. For information, contact Hutter, > MD, at (727) 467-2503. > > CAMPAIGN AWARDS went of two recipients: > 1. The Alabama Quality Assurance Foundation's " IZ Alabama > Covered? " Flu and Pneumonia Prevention Campaign aims > to increase influenza and pneumococcal vaccination rates > among senior adults. Recent data show a 66% increase in the > volume of doses of influenza vaccine administered in Alabama > from 2002 to 2003. For information, contact Betsy S. Frazer, > RN, BS, at (205) 970-1600 x3511. > > 2. Visiting Nurse Service,Inc.'s (VNS) Immunization Programs are > helping raise disease awareness and vaccination use in > Indianapolis. The number of influenza and pneumococcal > vaccines given by VNS increased by 22% from 2002 to 2003. VNS > has also raised meningococcal disease awareness and vaccine > use among high school seniors. For information, contact Judy > Moon at (317) 722-8200. > > THE NONTRADITIONAL PARTNER AWARD went to the Southeast Michigan > Partners Project, which brings together distinct communities, > including insurers, employers, and public health and other > stakeholders to develop projects that promote and implement > adult immunization services. For information, contact Terrisca > Des Jardins, MHSA, at (734) 769-1247. > > THE PROVIDER AWARD went to Norman Regional Hospital, which has > evaluated nearly 33,000 patients since 2000 and administered > more than 5,200 doses of pneumococcal vaccine to eligible > patients. For information, contact Yvette on at > (405) 307-1955. > > For additional information on the award-winning projects, go to: > http://www.partnersforimmunization.org/2004recipients.html > --------------------------------------------------------------- > > (8 of 11) > August 9, 2004 > NIP WEB SECTION PRESENTS DETAILED INFORMATION ON NEEDLE-FREE > INJECTION TECHNOLOGY > > NIP's web section Needle-free Injection Technology offers a > wealth of information on the technology involved in > administering vaccines and drugs through the skin without the > use of conventional needles. The section provides background > information, scientific bibliography, history, and links to news > reports, policy sources, device manufacturers, and related > sites. > > Among the resources available is the " Needle-free Injection > Technology News Service, " which distributes news and related > information by WebBoard forum postings and email broadcasts. To > browse as a guest or to subscribe, go to: > http://vaxdev.forum.cdc.gov > > To access all the offerings on the Needle-free Injection > Technology web section, go to: > http://www.cdc.gov/nip/dev/jetinject.htm > --------------------------------------------------------------- > > (9 of 11) > August 9, 2004 > NIP's FREE WEB-BASED TRAINING COURSE ON SMALLPOX VACCINE STORAGE > AND HANDLING IS APPROVED FOR CME CREDIT > > NIP and CDC recently announced the release of Smallpox Vaccine > Storage and Handling, a free interactive web-based training > course approved for CME credit. > > Presented in four modules, the course covers vaccine > distribution, vaccine storage, vaccine preparation and > administration, and procedures and equipment to safeguard the > vaccine during an emergency. The intended audience includes > state and local health department staff; hospital emergency room > technicians, nurses, laboratory workers, and hospital > physicians; private physicians; and first responders. > > To access additional information and the course itself, go to: > http://www2.cdc.gov/nip/isd/spoxvsh/launch1.html > > Email nipinfo@... with questions and comments. > --------------------------------------------------------------- > > (10 of 11) > August 9, 2004 > WHO ANNOUNCES RESUMPTION OF POLIO IMMUNIZATION CAMPAIGNS IN > KANO, NIGERIA > > On August 3, WHO issued a statement on behalf of the Global > Polio Eradication Initiative welcoming the resumption of polio > immunization campaigns in Kano, Nigeria. The first round of > campaigns began in Kano on July 31. Additional campaigns are > planned from September to November throughout Nigeria. > > The statement reported that Kano's decision to vaccinate > children against polio comes at a critical time in the polio > eradication program. Sub-Saharan Africa is on the verge of the > largest polio epidemic in recent history. Because of the > outbreak that originated in Kano and surrounding states, polio > cases recorded in the region are five times greater than they > were during the same period in 2003 (483 compared with 95). > > To access the complete statement, go to: > http://www.who.int/mediacentre/statements/2004/statement4/en/print.html > --------------------------------------------------------------- > > (11 of 11) > August 9, 2004 > SIGN'S ANNUAL MEETING SCHEDULED FOR OCTOBER 20-22 IN CAPE TOWN, > SOUTH AFRICA > > The Safe Injection Global Network (SIGN) recently announced it > will hold its annual meeting on October 20-22 in Cape Town, > South Africa. The meeting has four objectives: > > 1. Exchange information regarding global progress toward the > safe and appropriate use of injections worldwide > 2. Review progress of the various injection safety demonstration > projects in Africa > 3. Review progress of the three WHO needle-stick prevention > projects > 4. Review progress in infection control activities in Africa > > For additional information, go to: > http://www.who.int/injection_safety/en > > Persons interested in participating in the meeting are > encouraged to email the SIGN secretariat at sign@... > > =================================================================== > We hope you will forward this e-newsletter to others. > > Managing Editor: Dale (dale@...) > Editorial Assistant: Janelle Tangonan (janelle@...) > ISSN: 1526-1786 > > To subscribe or change your IACX email address, as well as to view > past issues, please visit http://www.immunize.org/express > > This publication is supported in part by Grant No. U66/CCU524042 > from the National Immunization Program, CDC, and Grant No. > U50/CCU523259 from the Division of Viral Hepatitis, CDC. Its > contents are solely the responsibility of IAC and do not necessarily > represent the official views of CDC. > Circulation: 17,862 > > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.